A Prospective Study of Publicly Funded Molecular Testing of Indeterminate Thyroid Nodules: Canada's Experience.
Florence LévesqueRichard J PayneDanielle BeaudoinAndrée BoucherPierre-Hugues FortierMarie-Hélène MassicotteMarc PusztaszeriGeneviève RondeauEdith CorriveauFarida El MaltMaryse BrassardPublished in: The Journal of clinical endocrinology and metabolism (2024)
Use of MT (TSv3) in a well-selected population with ITNs led to a BCR of 72.6%. It is cost-effective and prevents unnecessary surgeries in a public healthcare setting.